Research Publications

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG

The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients.

Pockros PJ, Reindollar R, McHutchinson J, Reddy R, Wright T, Boyd DG, Wilkes LB

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

Lee SS, Heathcote EJ, Reddy KR, Zeuzem S, Fried MW, Wright TL, Pockros PJ, Häussinger D, Smith CI, Lin A, Pappas SC

Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach.

Duchini A, Redfield DC, McHutchison JG, Brunson ME, Pockros PJ

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E

Developments in the treatment of chronic hepatitis C.

Pockros PJ

Natural progression of untreated hepatolithiasis.

Pockros PJ

Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.

Ferron GM, Preston RA, Noveck RJ, Pockros P, Mayer P, Getsy J, Turner M, Abell M, Paul J

Immune response to influenza vaccine in adult liver transplant recipients.

Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C.

Reddy KR, Wright TL, Pockros PJ, Shiffman M, Everson G, Reindollar R, Fried MW, Purdum PP 3rd, Jensen D, Smith C, Lee WM, Boyer TD, Lin A, Pedder S, DePamphilis J